Orange Book product · Brand (NDA)
CATAFLAM
DICLOFENAC POTASSIUM
At a glance
Nov 24, 1993
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 24, 1993
33 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
DICLOFENAC POTASSIUM
Strength
25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 020142
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2009CAMBIABrand (NDA)
NDA 022165 · ASSERTIO SPECLTY
- 2009ZIPSORBrand (NDA)
NDA 022202 · ASSERTIO SPECLTY
- 2025DICLOFENAC POTASSIUMGeneric (ANDA)
ANDA 217010 · UMEDICA
- 2025DICLOFENAC POTASSIUMGeneric (ANDA)
ANDA 215750 · UMEDICA
- 2025DICLOFENAC POTASSIUMGeneric (ANDA)
ANDA 215891 · TORRENT
- 2024DICLOFENAC POTASSIUMGeneric (ANDA)
ANDA 218011 · TARO
- 2023DICLOFENAC POTASSIUMGeneric (ANDA)
ANDA 215787 · SENORES PHARMS
- 2022DICLOFENAC POTASSIUMGeneric (ANDA)
ANDA 216635 · ALKEM LABS LTD
- 2022DICLOFENAC POTASSIUMGeneric (ANDA)
ANDA 215375 · ANNORA PHARMA
- 2021DICLOFENAC POTASSIUMGeneric (ANDA)
ANDA 213875 · AUROBINDO PHARMA LTD
- 2021DICLOFENAC POTASSIUMGeneric (ANDA)
ANDA 215585 · INGENUS PHARMS LLC
- 2021DICLOFENAC POTASSIUMGeneric (ANDA)
ANDA 075229 · RUBICON RESEARCH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

